Applying FRAME-IS to Characterize Provider-led Adaptations to a Cervical Cancer Prevention Intervention in Kenya.
Harriet Fridah Adhiambo, Kathy Thomas, Megan M Coe...
https://pubmed.ncbi.nlm.nih.gov/40709265/Actively Recruiting
Led by University of Washington · Updated on 2024-08-19
565
Participants Needed
1
Research Sites
31 weeks
Total Duration
Cervical cancer is a major health concern, especially in low- and middle-income countries like Kenya, where it remains the second most common cancer and leading cause of cancer death among women. Despite being largely preventable through early detection and treatment of pre-cancerous lesions, screening and treatment rates are low due to challenges such as equipment shortages and costs. This research aims to evaluate the implementation and cost of introducing thermal ablation, a safer and easier treatment alternative to cryotherapy, in reproductive health clinics in Kenya to improve cervical cancer prevention efforts. The study involves delivering the single visit screen-and-treat approach using thermal ablation SVA-SATTA at 10 reproductive health clinics in central Kenya. Thermal ablation uses local heating to destroy abnormal cervical tissue and can be powered by electricity, batteries, or solar energy. The research employs a stepped-wedge, cluster randomized design over five years to introduce and evaluate this approach using the RE-AIM framework, which assesses reach, effectiveness, adoption, implementation, and maintenance of the intervention. The study also includes cost and budget impact analyses comparing thermal ablation to cryotherapy. Participants include women seeking cervical cancer screening, women who test positive for pre-cancerous lesions, health care providers, and health managers. The study collects data through interviews, training records, treatment completion rates, HPV clearance tests, and clinic adoption measures. Outcomes include barriers and facilitators to implementation, the number of trained providers delivering treatment, sustained use of thermal ablation, and the impact on treatment uptake. Participant involvement spans up to four years with additional monitoring six months post-treatment for HPV clearance.
CONDITIONS
Cervical Cancer Elimination -Using Implementation Science to Evaluate Deliver and Cost Introduction of Thermal Ablation
L
Lynda Oluoch, MBChB, MPH
J
Jason Caucutt
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Washington
Lead Sponsor
National Cancer Institute (NCI)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single visit treatment with follow-up lasting up to 6 months
Women who screen positive for pre-cancer lesions of the cervix will receive thermal ablation treatment to destroy abnormal tissue in a single visit.
1 treatment visit and follow-up visits over 6 months
Duration - Up to 6 months after treatment
Participants will be followed up to assess the effectiveness of treatment, including Human Papillomavirus (HPV) clearance and sustained use of thermal ablation in clinics.
Follow-up visits during 6 months post-treatment
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Harriet Fridah Adhiambo, Kathy Thomas, Megan M Coe...
https://pubmed.ncbi.nlm.nih.gov/40709265/Michelle B Shin, Lynda Myra Oluoch, Ruanne V Barnabas...
https://pubmed.ncbi.nlm.nih.gov/37365575/Harriet Fridah Adhiambo, Katherine Thomas, Megan M Coe...
https://pubmed.ncbi.nlm.nih.gov/41731591/University of Washington
Lead Sponsor
National Cancer Institute (NCI)
Collaborating Sponsor